NCRI 2019 | Aberrrant transcriptional programming in AML
Constanze Bonifer, PhD, University of Birmingham, Birmingham, UK, talks about sub-type specific aberrant transcriptional programming in acute myeloid leukemia (AML). Recorded at the 2019 National Cancer Research Institute (NCRI) Annual Cancer Conference, in Glasgow, UK.
For more information about the NCRI Cancer Conference, visit https://conference.ncri.org.uk.
Get great new content delivered to your inboxSign up